1692-Chronotherapy in Immune Checkpoint Inhibitor Treatment
Chronotherapy involving immune checkpoint inhibitors demonstrates that the precise time of day when treatment is administered can significantly impact patient survival rates. While numerous retrospective studies and preclinical trials indicate that morning infusions yield superior anti-tumor responses compared to afternoon treatments, controversy remains due to conflicting findings and the long half-lives of these drugs. Researchers hypothesize that these temporal differences are driven by circadian immune variations, specifically regarding CD8+ T cell behavior and a potential refractory…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.